UOC
NTBL

UBS O'Connor’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

UBS O'Connor’s Portfolio NTBL Stock Details NTBL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,338
Closed -$277K – 866
2014
Q4 		$277K Buy
+1,338
New +$289K ﹤0.01% 558

Other funds holding NTBL

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

UBS O'Connor's NTBL Position: Q1 2015 in Review

UBS O'Connor sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q1 2015, closing a stake of 1,338 shares — an estimated $277K sold.

UBS O'Connor first reported a position in NTBL in Q4 2014 and held it in 1 quarter. The position peaked at $277K in Q4 2014. 8 funds tracked by Wall St. Rank hold NTBL as of Q1 2015.

  • UBS O'Connor reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q1 2015 after selling out during the quarter.
  • UBS O'Connor sold 1,338 Notable Labs, Ltd. Ordinary Shares shares in Q1 2015, an estimated $277K.
  • UBS O'Connor first reported a position in Notable Labs, Ltd. Ordinary Shares in Q4 2014 and held it in 1 quarter.
  • UBS O'Connor's Notable Labs, Ltd. Ordinary Shares position peaked at $277K in Q4 2014.
  • 8 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q1 2015.

Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.